Trial record 1 of 1 for:    NCT00568750
Previous Study | Return to List | Next Study

Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00568750
Recruitment Status : Active, not recruiting
First Posted : December 6, 2007
Last Update Posted : March 2, 2018
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : January 18, 2012
  Estimated Study Completion Date : December 2018